Are you Dr. McClure?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Rebecca McClure, MD is a board certified pathologist in Rochester, Minnesota. She is currently licensed to practice medicine in Minnesota.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pathology-Anatomic and Clinical, 1995 - 1999- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 1994 - 1995
University of Toronto Faculty of MedicineClass of 1994- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematopathology
Certifications & Licensure
MN State Medical License 1997 - 2025- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 5 citationsMultisite verification of the accuracy of a multi-gene next generation sequencing panel for detection of mutations and copy number alterations in solid tumoursJohn M. S. Bartlett, Yutaka Amemiya, Heleen H. Arts, Jane Bayani, Barry Eng
Plos One. 2021-10-01 - 26 citationsIbrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradicationPin Lu, Shengchun Wang, Carrie A. Franzen, Girish Venkataraman, Rebecca F. McClure
Blood Cancer Journal. 2021-02-18 - 35 citationsActivation of the pattern recognition receptor NOD1 augments colon cancer metastasisHenry Y. Jiang, Sara Najmeh, Guy Martel, Elyse MacFadden-Murphy, Raquel Farias
Protein & Cell. 2020-01-19
Press Mentions
How Women-Led Mutual Aid Initiatives Are Strengthening the COVID-19 ResponseMay 11th, 2020
AMP Addresses Clinical Relevance of DNA Variants in Chronic Myeloid NeoplasmsAugust 23rd, 2018
Retiring HSN Exec Proud of Research StridesDecember 27th, 2016
